500
Participants
Start Date
November 16, 2018
Primary Completion Date
November 29, 2021
Study Completion Date
September 30, 2024
LAmbre Occluder
All patients are implanted with Lifetech LAmbre occluder device.
901 - Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok
104 - Charité Campus Benjamin Franklin (CBF), Berlin
107 - Charité Campus Virchow-Klinikum, Berlin
401 - Centro Cardiologico Monzino, Milan
403 - ASST Grande Ospedale Metropolitano Niguarda, Milan
601 - University Hospital of Salamanca/Hospital Clínico Universitario de Salamanca, Salamanca
801 - Sahlgrenska Universitetssjukhuset/Sahlgrenska University Hospital, Gothenburg
102 - Alfried Krupp Hospital Ruettenscheid, Essen
105 - UKB Universitätsklinikum Bonn, Bonn
113 - Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz
101 - CVC CardioVasculäres Centrum Frankfurt, Frankfurt
109 - Cardioangiologisches Centrum Bethanien (CCB), Frankfurt
406 - Clinica Mediterranea S.P.A./Clinica Mediterranea - Ospedale e Centro Diagnostico, Napoli
106 - Peter Osypka Herzzentrum, München
501 - Wojewódzki Specjalistyczny Szpital im. dr. Wł. Biegańskiego, Lodz
111 - Klinikum Coburg GmbH, Coburg
1001 - HKU Queen Mary Hospital, Hong Kong
201 - Aarhus Universitetshospital, Aarhus
114 - Facharztzentrum Dresden-Neustadt GbR, Dresden
108 - Universitätsklinikum Jena, Jena
103 - Klinikum St. Georg gGmbH, Leipzig
110 - Herzzentrum Leipzig (HZL), Leipzig
301 - Mater Misericordiae University Hospital, Dublin
405 - La Struttura ASL Roma 2, Roma
603 - FundacióInstitut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona
602 - Hospital Clínic de Barcelona, Barcelona
Collaborators (1)
IQVIA Biotech
INDUSTRY
Lifetech Scientific (Shenzhen) Co., Ltd.
INDUSTRY